Steven P. Howard, MD, PhD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Steven P. Howard, MD, PhD, earned his medical degree from the University of Wisconsin School of Medicine and Public Health, (formerly UW Medical School), Madison, WI and completed his residency at the Joint Center for Radiation Therapy of the Harvard Medical School. He is a member of the UW Health Breast Center.
UW Health Clinics
UW School of Medicine and Public Health
|Department of Human Oncology|
Professional Certifications and Education
Harvard Hospitals, Memorial Sloan-Kettering Cancer Center, NY
Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA
Beth Israel Hospital, Boston, MA
University of Wisconsin School of Medicine and Public Health (formerly UW Medical School), Madison, WI, 1990
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Bender E Kozak K Howard S Hayes L Bayouth J Robins HI .
The effect of Optune™ Tumor Treating Fields transducer arrays on skin radiation dose during radiotherapy. J Clin Neurosci. 2017 Aug;42:172-175
[PubMed ID: 28427800]
Howard SP Krauze A Chan MD Tsien C Tomé WA .
The evolving role for re-irradiation in the management of recurrent grade 4 glioma. J Neurooncol. 2017 Apr 6;
[PubMed ID: 28386661]
Rajesh D Robins HI Howard SP .
Karenitecin (bnp1350) and flavopridol as radiosensitizers in malignant glioma. J Neurol Neuromedicine. 2016;1(6):1-10
[PubMed ID: 28111642]
Welsh JS Howard SP .
Comment on "A Novel Thymoma-Associated Immunodeficiency with Increased Naive T Cells and Reduced CD247 Expression". J Immunol. 2015 Oct 15;195(8):3505
[PubMed ID: 26432897]
Sudmeier LJ Samudrala SS Howard SP Ganetzky B .
Persistent Activation of the Innate Immune Response in Adult Drosophila Following Radiation Exposure During Larval Development. G3 (Bethesda). 2015 Sep 1;5(11):2299-306
[PubMed ID: 26333838]
Sudmeier LJ Howard SP Ganetzky B .
A Drosophila model to investigate the neurotoxic side effects of radiation exposure. Dis Model Mech. 2015 Jul 1;8(7):669-77
[PubMed ID: 26092528]
Magnuson W Ian Robins H Mohindra P Howard S .
Large volume reirradiation as salvage therapy for glioblastoma after progression on bevacizumab. J Neurooncol. 2014 Mar;117(1):133-9
[PubMed ID: 24469853]
Mohindra P Robins HI Tomé WA Hayes L Howard SP .
Wide-field pulsed reduced dose rate radiotherapy (PRDR) for recurrent ependymoma in pediatric and young adult patients. Anticancer Res. 2013 Jun;33(6):2611-8
[PubMed ID: 23749916]
Rong Y Paliwal B Howard SP Welsh J .
Treatment planning for pulsed reduced dose-rate radiotherapy in helical tomotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):934-42
[PubMed ID: 20884127]
Adkison JB Tomé W Seo S Richards GM Robins HI Rassmussen K Welsh JS Mahler PA Howard SP .
Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):835-41
[PubMed ID: 20472350]
Rasmussen KH Hardcastle N Howard SP Tomé WA .
Reirradiation of glioblastoma through the use of a reduced dose rate on a tomotherapy unit. Technol Cancer Res Treat. 2010 Aug;9(4):399-406
[PubMed ID: 20626205]
Richards GM Tomé WA Robins HI Stewart JA Welsh JS Mahler PA Howard SP .
Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region. Breast Cancer Res Treat. 2009 Mar;114(2):307-13
[PubMed ID: 18389365]
Adkison JB Thomadsen B Howard SP .
Systemic iodine 125 activity after GliaSite brachytherapy: safety considerations. Brachytherapy. 2008 Jan-Mar;7(1):43-6
[PubMed ID: 18201938]
Cannon GM Tomé WA Robins HI Howard SP .
Pulsed reduced dose-rate radiotherapy: case report : a novel re-treatment strategy in the management of recurrent glioblastoma multiforme. J Neurooncol. 2007 Jul;83(3):307-11
[PubMed ID: 17252184]
De Stasio G Rajesh D Ford JM Daniels MJ Erhardt RJ Frazer BH Tyliszczak T Gilles MK Conhaim RL Howard SP Fowler JF Estève F Mehta MP .
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei. Clin Cancer Res. 2006 Jan 1;12(1):206-13
[PubMed ID: 16397044]
Fenske TS Kahl BS Eickhoff J Mitchell TL Smith EP Atkinson E McCoy AG Eckstein L Flynn B McMannes J Howard S Longo WL .
Excessive toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mantle cell lymphoma. Leuk Lymphoma. 2005 Oct;46(10):1441-8
[PubMed ID: 16194889]
De Stasio G Rajesh D Casalbore P Daniels MJ Erhardt RJ Frazer BH Wiese LM Richter KL Sonderegger BR Gilbert B Schaub S Cannara RJ Crawford JF Gilles MK Tyliszczak T Fowler JF Larocca LM Howard SP Mercanti D Mehta MP Pallini R .
Are gadolinium contrast agents suitable for gadolinium neutron capture therapy? Neurol Res. 2005 Jun;27(4):387-98
[PubMed ID: 15949236]
Welsh JS Limmer JP Howard SP Diamond D Harari PM Tome W .
Precautions in the use of intensity-modulated radiation therapy. Technol Cancer Res Treat. 2005 Apr;4(2):203-10
[PubMed ID: 15773789]
Allen GW Forouzannia A Bailey HH Howard SP .
Non-Hodgkin's lymphoma presenting as a pelvic mass with elevated CA-125. Gynecol Oncol. 2004 Sep;94(3):811-3
[PubMed ID: 15350377]
Fowler JF Welsh JS Howard SP .
Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):242-9
[PubMed ID: 15093921]